NPP 150
Nandrolone Phenylpropionate
Nandrolone Phenylpropionate β NPP 150 by Dragon Pharma
NPP 150 is Dragon Pharma's formulation of injectable Nandrolone Phenylpropionate at 150mg/ml β the original short-ester form of Nandrolone that predates Deca-Durabolin by several years. Each 10ml vial in Dragon Pharma's MCT oil carrier delivers the same anabolic compound as Deca 300, but with a shorter ester that fundamentally changes its cycle dynamics, side effect management and detection window.
Also searched as: NPP 150mg, Nandrolone Phenylpropionate, Durabolin (original), NPP Dragon Pharma.
NPP Is the Original Nandrolone β The Historical Context
A fact rarely mentioned in competitor content: Nandrolone Phenylpropionate is not a shorter-ester variant of Deca β it is the original:
- Nandrolone Phenylpropionate was first introduced commercially as "Durabolin" by Organon in 1959
- Nandrolone Decanoate ("Deca-Durabolin") was introduced later in 1962 as a longer-acting version designed for less frequent injection
- NPP was therefore the compound bodybuilders and athletes used throughout the 1960s before Deca replaced it in mainstream use due to the convenience of weekly injections
- The modern resurgence of NPP reflects a shift back toward shorter esters for better cycle control β NPP is now often preferred by experienced users precisely because of what makes Deca inconvenient: its very long ester
NPP vs Deca β Quantified Ester Comparison
The same active compound, fundamentally different pharmacokinetics:
| Parameter | NPP 150 (Phenylpropionate) | Deca 300 (Decanoate) |
|---|---|---|
| Ester | Phenylpropionate | Decanoate |
| Half-life | ~5 days | ~15 days |
| Time to steady-state | ~25 days (5 half-lives) | ~75 days (5 half-lives) |
| Minimum cycle length | 8β10 weeks practical | 14β16 weeks minimum |
| Side effect offset after stopping | ~2β3 weeks | ~6β8 weeks |
| PCT start (after last injection) | ~10β14 days post | ~3β4 weeks post |
| WADA detection window | ~12β18 months | ~18 months+ |
| Injection frequency | Every other day or 3Γ weekly | Weekly or twice weekly |
The detection window data is particularly significant and rarely published clearly in competitor content: despite NPP's shorter half-life, its WADA detection window remains approximately 12-18 months β substantially shorter than Deca's 18+ months, but still among the longest of any AAS. Both compounds produce a nandrolone metabolite (19-norandrosterone) detectable in urine by WADA-accredited laboratories for this extended period.
Why Experienced Users Often Prefer NPP Over Deca
Three specific advantages over Deca that competitor content rarely articulates clearly:
- Side effect management: If prolactin-related issues arise ("NPP dick"), they resolve within 2-3 weeks of stopping rather than 6-8 weeks with Deca β the shorter ester provides a meaningful escape window if the cycle needs to be halted
- Shorter cycle feasibility: A 10-week NPP cycle actually reaches steady-state and provides effective work time β a 10-week Deca cycle is largely wasted because blood levels barely stabilise before the cycle ends
- Faster PCT initiation: PCT can begin approximately 10-14 days after the last NPP injection vs 3-4 weeks for Deca β meaningful for recovery timeline
Effects and Benefits
- Lean mass gains with lower water retention than testosterone at equivalent doses
- Notable joint comfort benefits during high-volume training β same mechanism as Deca via collagen synthesis effects
- Faster onset than Deca β reaches effective levels within days rather than weeks
- More manageable prolactin-related side effects due to faster clearance if needed
- Lower androgenic activity than testosterone β favourable anabolic-to-androgenic ratio
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
Comments (0)
Your review appreciation cannot be sent
Report comment
Report sent
Your report cannot be sent